Advertising Press Release Distribution |   Reality TV   |  Lifestyle Magazine  |  Kiev Plastic Surgery

Lazer MedSpa News

Everything you need to know about lasers​

Lazer MedSpa News

Day: November 10, 2022

BeautyLaser Treatment

Reveal Lasers Announces Distribution Agreement With Advalight

Reveal Lasers Announces Distribution Agreement With AdvalightThe aesthetic device innovator’s partnership with Advalight builds on the company’s continued vision for global expansion and market development.

Reveal Lasers Announces Distribution Agreement With Advalight
ADVATx

Combining the gold standard wavelength for eliminating vascular abnormalities with the new gold standard for non-ablative resurfacing, the ADVATx allows the provider to treat multiple FDA-cleared indications without the use of consumables.

LAS VEGAS – November 10, 2022 – (Newswire.com)

Reveal Lasers LLC, a wholly owned subsidiary of Reveal Lasers LTD, is pleased to announce their marketing and distribution agreement with Advalight, global manufacturers of the ADVATx device, the world’s only medical, solid-state laser producing both 589nm and 1319nm wavelengths. 

For Advalight, partnering with Reveal Lasers provides a proven and growing distribution team in North America to further launch ADVATx. This aligns with Advalight’s mission to grow the brand globally. With numerous FDA-cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx has been adopted as the laser modality of choice for physicians dedicated to offering their patients the safest and most advanced laser solutions available. 

Travis Mahan, President of Advalight, stated, “Partnering with Reveal Lasers represents an important milestone in the growth of ADVATx in North America. The leadership team at Reveal has a demonstrated track record of successfully bringing groundbreaking technology like the ADVATx to the aesthetics market, and we are thrilled to pair our best-in-class technology with their world-class sales, marketing and practice support acumen.”

“Reveal Lasers is excited to partner with Advalight to further expand the reach of their ADVATx device in North America,” said Bob Daley, CEO of Reveal Lasers. “ADVATx is a global brand known around the world for its stellar manufacturing and superior clinical outcomes for patients and providers.” 

To learn more about Reveal Lasers LLC and ADVATx, visit us.reveallasers.com

About Reveal Lasers

Reveal Lasers LTD is a global leader in the innovation of minimally invasive cosmetic surgical procedures, medical treatments, and aesthetic solutions for providers and clinics. Born from a group of aesthetic industry veterans boasting over 50 years of collective industry experience, the company’s skills and expertise primarily encompass the development of energy Laser, Radiofrequency (RF), and Intense Pulse Light (IPL). The manufacturer ensures the uncompromising quality of products and the highest return on investment in the industry while committing to complete customer satisfaction by offering its partners a comprehensive support system for product implementation, marketing, and more.

About Advalight

Advalight is the company behind ADVATx and was founded in 2006 as a result of their founder’s Ph.D. studies at the Technical University of Denmark. The company is headquartered in Copenhagen, Denmark, and has a sales and service office in San Diego, CA, USA. ADVATx is available through our network of global distributors.

Contact Information:

Dean Fiacco

VP of Operations

dean.fiacco@reveallasers.com

(518)527-2558

Press Release Service
by
Newswire.com

Original Source:

Reveal Lasers Announces Distribution Agreement With Advalight

Read More
BeautyLaser Treatment

Reveal Lasers Announces Distribution Agreement With Advalight

Reveal Lasers Announces Distribution Agreement With AdvalightThe aesthetic device innovator’s partnership with Advalight builds on the company’s continued vision for global expansion and market development.

Reveal Lasers Announces Distribution Agreement With Advalight
ADVATx

Combining the gold standard wavelength for eliminating vascular abnormalities with the new gold standard for non-ablative resurfacing, the ADVATx allows the provider to treat multiple FDA-cleared indications without the use of consumables.

LAS VEGAS – November 10, 2022 – (Newswire.com)

Reveal Lasers LLC, a wholly owned subsidiary of Reveal Lasers LTD, is pleased to announce their marketing and distribution agreement with Advalight, global manufacturers of the ADVATx device, the world’s only medical, solid-state laser producing both 589nm and 1319nm wavelengths. 

For Advalight, partnering with Reveal Lasers provides a proven and growing distribution team in North America to further launch ADVATx. This aligns with Advalight’s mission to grow the brand globally. With numerous FDA-cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx has been adopted as the laser modality of choice for physicians dedicated to offering their patients the safest and most advanced laser solutions available. 

Travis Mahan, President of Advalight, stated, “Partnering with Reveal Lasers represents an important milestone in the growth of ADVATx in North America. The leadership team at Reveal has a demonstrated track record of successfully bringing groundbreaking technology like the ADVATx to the aesthetics market, and we are thrilled to pair our best-in-class technology with their world-class sales, marketing and practice support acumen.”

“Reveal Lasers is excited to partner with Advalight to further expand the reach of their ADVATx device in North America,” said Bob Daley, CEO of Reveal Lasers. “ADVATx is a global brand known around the world for its stellar manufacturing and superior clinical outcomes for patients and providers.” 

To learn more about Reveal Lasers LLC and ADVATx, visit us.reveallasers.com

About Reveal Lasers

Reveal Lasers LTD is a global leader in the innovation of minimally invasive cosmetic surgical procedures, medical treatments, and aesthetic solutions for providers and clinics. Born from a group of aesthetic industry veterans boasting over 50 years of collective industry experience, the company’s skills and expertise primarily encompass the development of energy Laser, Radiofrequency (RF), and Intense Pulse Light (IPL). The manufacturer ensures the uncompromising quality of products and the highest return on investment in the industry while committing to complete customer satisfaction by offering its partners a comprehensive support system for product implementation, marketing, and more.

About Advalight

Advalight is the company behind ADVATx and was founded in 2006 as a result of their founder’s Ph.D. studies at the Technical University of Denmark. The company is headquartered in Copenhagen, Denmark, and has a sales and service office in San Diego, CA, USA. ADVATx is available through our network of global distributors.

Contact Information:

Dean Fiacco

VP of Operations

dean.fiacco@reveallasers.com

(518)527-2558

Press Release Service
by
Newswire.com

Original Source:

Reveal Lasers Announces Distribution Agreement With Advalight

Read More
Health

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning TechnologyThe Covid-19 Detection Foundation (Dba Virufy) is the newest member of BARDA’S division of research, innovation, and ventures (DRIVe) medical countermeasures portfolio

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology
Virufy

SAN FRANCISCO – November 10, 2022 – (Newswire.com)

Lessons learned from the COVID-19 pandemic underscore the need for more rapidly scalable, low-cost, and broadly available approaches in responding to public health emergencies. Digital tools like smartphone or web-based applications present opportunities for new classes of medical countermeasures that could complement traditional approaches. Aiming for easy detection of Covid-19, Virufy has created an IA-based app that should make the diagnosis of the disease more inclusive.

Through AI/ML algorithms, smartphone and computer applications can use images and audio captured with the phone or computer’s existing hardware to assess aspects of a person’s health. Health-related image and audio recordings contain much more information than the human eye or ear alone can process, but AI/ML algorithms could be used to process that information, detect differences and patterns among images and sounds, and identify disease signatures. These digital tools could empower individuals with actionable information about their infection status or acute skin condition and symptoms so that they can self-isolate and seek medical care if appropriate.

Virufy is developing an app that uses a few seconds of cough audio, collected through a smartphone or computer microphone, to identify cough patterns indicative of a current COVID-19 infection. Virufy has demonstrated this capability based on an analysis of several thousand samples from international clinical networks and through crowdsourcing. With DRIVe’s support, Virufy will conduct additional clinical studies to refine and test their algorithm. Virufy will also initiate proof-of-concept work on AI algorithms to screen for other respiratory diseases based on cough audio.

VisualDx aims to create an AI/ML algorithm that analyzes user-provided skin lesion images together with a symptom questionnaire on a smartphone app. The algorithm can provide information on the indicated disease and other similarly presenting conditions. If successful, this project would demonstrate the power of AI/ML-based image analysis for easily and rapidly accessible symptom checking for potentially any pox-based virus such as smallpox or monkeypox, and provide a digital health solution that could be modified easily in a future outbreak.

BARDA’s 2022-2026 Strategic Plan emphasizes the importance of preparing for future public health emergencies by collaborating with innovators to develop medical countermeasures that can help save lives. Cutting-edge, digital guidance tools that can pivot and be brought to scale in response to new threats could aid in public health response. These DRIVe projects, if successful, could demonstrate the power of these tools to rapidly respond to other threats such as influenza and smallpox.

These awards have been made under the Easy Broad Agency Announcement (EZ-BAA) area of interest (AOI) #9: Digital Medical Countermeasures.

This project has been funded in part with Federal funds from HHS/ASPR and BARDA, under Contract No. 75A50122C00034.

Contact Information:

Patricia Zylberman

PR Manager

patricia@sherlockcomms.com

+5511972447743

Press Release Service
by
Newswire.com

Original Source:

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology

Read More
Advertising Business Newspaper |   Miami News   |   Lifestyle Magazine  |   Fashion Magazine | Digital Newspaper Lifestyle Magazine | Woman Magazine Lifestyle News Politic News |   Miami News   |   Lifestyle Magazine |   Politics News   |   Lifestyle Magazine